Cataract Reports

The “2022 Premium Cataract Surgery Market Report” is designed to provide insight into the most important premium cataract surgery (PCS) markets in the world. We’ve selected and profiled 13 countries that collectively account for 84 percent of global PCS manufacturer revenue and provided a deep dive into each of these markets. Ranked by 2022 PCS manufacturer revenue, they are: the US, China, South Korea, Japan, Brazil, Germany, Canada, Australia, France, India, Spain, the UK, and Italy.

It is our perception that companies planning to market premium cataract surgery devices often have only a general understanding of the size and characteristics of these key country markets. For each of these countries, we focus on specific characteristics considered vital to the understanding of the PCS opportunities there.

The “2023 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. 

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs. Additionally, 34 companies are profiled, with discussion of their products, strategic market position, background, and outlook.

The “2023 Single-Use Ophthalmic Surgical Products Market Report” examines global and regional markets for single-use ophthalmic surgical products. The report reviews cataract surgery, the dominant procedure in this market, as well as cataract surgery providers worldwide. Market segments profiled are: viscoelastics, knives, disposable instruments, balanced salt solutions, procedure packs, drapes, sutures, fluid management devices, eye shields, ocular dyes, capsular tension rings, and cautery pencils.

The “2023 Cataract Surgical Equipment Market Report” provides in-depth analysis of the global cataract surgical equipment market, examining the market’s size and growth, as well as identifying important developments that may shape its future. The analysis focuses on the 2023 market and forecasts growth and evolution through 2028. Product demand is forecast in units and dollars, and market shares are analyzed by product category. Additionally, 20 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our US Cataract Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

The “2023 China Ophthalmic Market Report” covers all aspects of China’s ophthalmic market, providing a comprehensive overview of the Chinese population and economic conditions, discussing key strategic issues, studying disease prevalence, and analyzing surgical and therapeutic approaches, including both commercialized and pipeline products. The report analyzes unit demand and revenue, and forecasts future performance over the next five years. Competitor share is analyzed by product category and 32 competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

Market Scope surveyed US ophthalmic surgeons during March and April 2023 to measure perceptions of practice patterns, product market share, and plans for the coming year. We received 119 responses from doctors performing cataract procedures, representing over one thousand total doctors in single doctor and group practices.

We have conducted annual surveys of US cataract surgeons on important issues regarding practice characteristics, product preferences, surgical techniques, and practice marketing since 2001. This survey highlights practice patterns regarding presbyopic-correcting IOLs (PC-IOLs), toric IOLs, extended depth of focus (EDOF) IOLs, correction of astigmatism, femtosecond laser-assisted cataract surgery (FLACS), sugical location, interest in upcoming technology, equipment use, treatment and management of glaucoma and micro-invasive glaucoma survery (MIGS) devices and much more. It measures market share by manufacturer, product, and market segment. Leading ophthalmic firms and organizations sponsor the survey in order to better understand industry dynamics and gain important insights into surgeons’ experiences and preferences, as well as emerging trends. 

The “2023 US and Western Europe Cataract Pharmaceuticals Market Report” offers an in-depth examination of the current cataract pharmaceuticals market in the United States and Western Europe and forecasts market performance over the next five years. The report analyzes the current market and forecasts units, average sales price, and revenue through 2028 by product category. It analyzes products currently on the market and examines the development pipeline, discusses the popularity of intracameral injections and fixed combination eye drops, and analyzes the roles of brand name medications, generics, and compounded formulations.

The “2023 United States Cataract Atlas” provides a geographic analysis of the conventional and premium cataract surgery opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index™ Analysis examines market potential and provides a benchmark against other metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

Market Scope’s “2022 European Five Ophthalmic Market Report” analyzes the ophthalmic market in Western Europe’s five largest economies, discussing important trends and key factors for future success in 11 ophthalmic submarkets. The report includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. It profiles ophthalmic companies in the five markets, provides analysis of current markets, and offers five-year forecasts of market performance.